Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

Roberto Mina, Angelo Belotti, Maria Teresa Petrucci, Renato Zambello, Andrea Capra, Giacomo Di Lullo, Sonia Ronconi, Norbert Pescosta, Mariella Grasso, Federico Monaco, Claudia Cellini, Marco Gobbi, Stelvio Ballanti, Paolo de Fabritiis, Maria Letizia Mosca-Siez, Monia Marchetti, Anna Marina Liberati, Massimo Offidani, Nicola Giuliani, Roberto RiaPellegrino Musto, Alessandra Romano, Pieter Sonneveld, Mario Boccadoro, Alessandra Larocca

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)58
JournalBlood Cancer J.
Volume10
Issue number5
DOIs
Publication statusPublished - May 18 2020

Cite this